|
Originally published In Press as doi:10.1074/jbc.M108627200 on October 4, 2001
J. Biol. Chem., Vol. 276, Issue 49, 46004-46010, December 7, 2001
Structure and Function of the Escherichia coli RecE
Protein, a Member of the RecB Nuclease Domain Family*
Hoshing Wan
Chang and
Douglas A.
Julin
From the Department of Chemistry and Biochemistry, University of
Maryland, College Park, Maryland 20742
Received for publication, September 6, 2001
 |
ABSTRACT |
The RecB subunit of the Escherichia
coli RecBCD enzyme has both helicase and nuclease activities. The
helicase function was localized to an N-terminal domain, whereas the
nuclease activity was found in a C-terminal domain. Recent analysis has
uncovered a group of proteins that have weak amino acid sequence
similarity to the RecB nuclease domain and that are proposed to
constitute a family of related proteins (Aravind, L., Walker, D. R., and Koonin, E. V. (1999) Nucleic Acids Res. 27, 1223-1242). One is the E. coli RecE protein (exonuclease
VIII), an ATP-independent exonuclease that degrades the 5'-terminated
strand of double-stranded DNA. We have made mutations in several
residues of RecE that align with the critical residues of RecB, and we
find that the mutations reduce or abolish the nuclease activity of RecE
but do not affect the enzyme binding to linear double-stranded DNA.
Proteolysis experiments with subtilisin show that a stable
34-kilodalton C-terminal domain that contains these critical residues
has nuclease activity, whereas no stable proteolytic fragments
accumulate from the N-terminal portion of RecE. These results show that
RecE has a nuclease domain and active site that are similar to RecB,
despite the very weak sequence similarity between the two proteins.
These similarities support the hypothesis that the nuclease domains of
the two proteins are evolutionarily related.
 |
INTRODUCTION |
The RecBCD enzyme from Escherichia coli and other
bacteria is a nuclease and a DNA helicase that plays an important role
in homologous recombination and recombinational DNA repair (reviewed in
Ref. 1). The RecB subunit of this enzyme by itself catalyzes both DNA
unwinding (2) and DNA cleavage (3, 4), although at greatly reduced
rates compared with RecBCD. These two activities are catalyzed by
independent structural domains of RecB (3). The N-terminal
three-quarters of the protein has helicase activity, whereas the
~30-kDa C-terminal portion of RecB constitutes a separate domain that
exhibits very weak endonuclease activity (3, 5). Despite its very low
nuclease activity, the C-terminal domain of RecB is critical for RecBCD
enzyme activity, because mutations in this part of RecB abolish the
nuclease activity of RecBCD (4, 6).
The N-terminal helicase domain of RecB is clearly related by amino acid
sequence similarity to a large group of DNA helicases that includes the
Rep, UvrD, and PcrA helicases from bacteria as well as enzymes
from eukaryotic organisms and viruses (7). On the other hand, the RecB
nuclease domain bears no obvious relation to any other nucleases. The
only proteins that have significant similarity scores in a simple BLAST
data base search that uses the nuclease domain from E. coli
RecB as the query sequence (residues 930-1180 of RecB) are RecB
homologues from other bacteria. This analysis thus sheds no light on
the evolutionary origin of the nuclease domain in RecB nor on whether
any other enzymes have domains that are related to the RecB nuclease domain.
More sophisticated sequence analysis by Koonin and co-workers (8) using
PSI-BLAST and other programs has uncovered a weak similarity between
the C-terminal region of RecB and a number of other sequences in the
GenBankTM data base. The set of 33 proteins that turned up
was dubbed the "RecB nuclease domain family" and is proposed to
constitute a group of proteins that are related structurally and
evolutionarily. The structures of five of these proteins are shown
schematically in Fig. 1A, and
the amino acid sequence that defines the "RecB family" is given in
Fig. 1B. Some of the family members are hypothetical and
uncharacterized open reading frames from completely sequenced genomes
(e.g. the sequence shown from Archaeoglobus
fulgidus), but a few are proteins that have been studied
previously. AddA is a RecB homologue from Bacillus subtilis
that assembles with AddB to make a two-subunit enzyme (AddAB) that
performs essentially the same enzymatic and biological functions as
RecBCD (9). The eukaryotic Dna2 protein has both nuclease and helicase
activities (10, 11), and the enzyme encoded by the recE gene
is a dsDNA1-specific nuclease
known as exonuclease VIII (12).

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 1.
A, structural organization of five of
the RecB nuclease domain family members. The black boxes
indicate the region of amino acid sequence similarity among the family
members identified by Aravind et al. (8). The gray
boxes indicate a helicase domain found in RecB and some other
members of the family. GenBankTM gene accession numbers are
as follows: E. coli RecB, 119668; B. subtilis
AddA, 113345; A. fulgidus hypothetical open reading frame,
2650653; S. cerevisiae Dna2, 731738; E. coli
RecE, 2507105. B, conserved amino acid sequence that defines
the RecB nuclease domain family. The residues in bold and
marked with an asterisk are those we changed previously in
RecB (Asp-1067, Asp-1080, Lys-1082, and Tyr-1114). The corresponding
residues in RecE are Asp-748, Asp-759, Lys-761, and Tyr-785.
Numbers in the right-most column indicate the
total number of amino acid residues in the protein; numbers
in the left-most column indicate the number of residues to
the N terminus; and numbers within the sequences
indicate the number of residues omitted for clarity.
|
|
The recE gene is situated within a cryptic
prophage called rac that is found in the chromosome of some
E. coli strains (13, 14). The RecE protein and the RecT
protein, encoded by a neighboring gene and functionally similar to the
E. coli RecA protein, can substitute for RecBCD and RecA in
some types of homologous recombination (15). The RecE enzyme is a
5'-3'-specific exonuclease that degrades processively one strand of a
linear dsDNA substrate to mononucleotide products (16, 17). RecE (866 amino acid residues) is quite a bit larger than the RecB nuclease
domain (253 residues), but the sequence that RecE has in common with
RecB is found near the C terminus of RecE (Fig. 1A) (8).
Previous work using deletion mutants has shown that a large fraction of
the N terminus of RecE can be deleted without loss of nuclease activity
(18-20).
The overall sequence similarity among the proteins in the putative RecB
family is very low, and thus the question arises as to its structural
and mechanistic significance. The answer must come from biochemical and
structural study of these proteins. We have begun by carrying out
mutagenesis and proteolysis experiments with the E. coli
RecE protein. First, we altered by site-directed mutagenesis the
residues that are conserved among the RecB family members and
determined their importance in the nuclease reaction. Second, we
investigated the domain structure of RecE by limited proteolysis. The
results confirm the relation between RecE and RecB that was proposed
from the sequence analysis.
 |
EXPERIMENTAL PROCEDURES |
Materials
Restriction enzymes, calf intestinal phosphatase, and
T4 DNA ligase were obtained from Promega or New England
Biolabs and were used as recommended by the suppliers. Subtilisin
Carlsberg and trypsin were purchased from Sigma, and thrombin was from
Novagen, Inc. Turbo Pfu DNA polymerase for PCR was obtained
from Stratagene. Oligonucleotides for PCR and mutagenesis were obtained
from Life Technologies, Inc. The plasmid pRAC31 that contains the
E. coli recE gene (13) was a gift from Prof. A. J. Clark, University of California, Berkeley. 3H-Labeled
plasmid DNA (pTZ19R-recEBHM (4023 bp, see below)
and pPvSm19 (6250 bp (21))) were isolated from cultures of E. coli strains JM109 or XL-1 grown as described previously (22). The
DNA was purified using the Qiafilter Plasmid Maxi kit (Qiagen, Inc.)
according to the manufacturer's protocol.
Methods
Construction of a Plasmid Expressing the His-tagged RecE Protein
(pET15b-recE)--
The His-tagged RecE protein (HisRecE) was expressed
using the vector pET15b (Novagen, Inc.). The recE gene was
transferred to the vector as follows. A 2601-bp fragment from the
plasmid pRAC31 that encompasses the recE gene was amplified
by PCR. The downstream primer annealed at the 3'-end of the gene and
introduced an XhoI site (bold) after the RecE
stop codon (primer recE xho1, 5'-GG GGT CTC GAG
TTA GTC ATT TGC
ATA TTC CTT AGC
CC). The upstream primer annealed at the 5'-end of the gene
and introduced an NdeI site at the start of the RecE coding
region (primer recE nde1, 5'-G CAA AAA CAT
ATG AGC ACA
AAA CCA CTC TTC
C). Both primers are partially complementary to the
recE gene (underlined). The amplified 2601-bp fragment was
digested with NdeI and XhoI and ligated into
pET15b to produce pET15b-recE. The recE gene insert in pET15b-recE was sequenced completely.
Site-directed Mutagenesis of the recE Gene--
The
site-directed mutagenesis was done using the QuikChange site-directed
mutagenesis kit (Stratagene) by one of the following two procedures. 1)
The pET15b-recE plasmid was used directly as the template
for site-directed mutagenesis for the Y785F mutation. 2) A 1165-bp
BamHI fragment, which encodes the C terminus of RecE protein, was first subcloned to pTZ19R to make
pTZ19R-recEBHM. This plasmid was then used as
the template for the D748A, D759A, K761Q, and Y785N mutations. The
different mutated 1165-bp fragments were ligated back into
pET15b-recE to express the mutant proteins.
The oligonucleotides used for the mutagenesis are as follows: 5'-GT CGG
TGC CGT CCG GCC AAA ATT ATC CCT G and 5'-C AGG GAT AAT TTT
GGC CGG ACG GCA CCG AC for the D748A mutation; 5'-CAC TGG
ATC ATG GCC GTG AAA ACT ACG GCG and 5'-CGC CGT AGT TTT CAC GGC CAT GAT CCA GTG for the D759A mutation; 5'-CAC TGG ATC
ATG GAC GTG CAA ACT ACG GCG GAT ATT C and 5'-G AAT ATC CGC
CGT AGT TTG CAC GTC CAT GAT CCA GTG for the K761Q mutation;
5'-C GTT CAG GAT GCA TTC TTC AGT GAC GGT TAT GAA GCA C and
5'-G TGC TTC ATA ACC GTC ACT GAA GAA TGC ATC CTG AAC G for
the Y785F mutation; and 5'-C GTT CAG GAT GCA TTC AAC AGT
GAC GGT TAT GAA GC and 5'-GC TTC ATA ACC GTC ACT GTT GAA
TGC ATC CTG AAC G for the Y785N mutation. The mutagenic nucleotides are
underlined. The reaction conditions and subsequent manipulations were
performed according to the manufacturer's protocol. Plasmids
containing the mutant genes were identified by restriction digestion
and DNA sequencing.
Purification of His-tagged RecE Proteins--
The
HisRecE protein was expressed in E. coli strain BL21(DE3)
transformed with pET15b recE. A 70-ml overnight culture in LB broth
containing ampicillin (50 µg/ml) was transferred to 2 liters of the
same medium. The cells were grown at 37 °C until the
A600 = 0.5. Isopropyl- -D-thiogalactopyranoside was then added to 1 mM, and growth was continued for 1 h before the cells
were harvested. The cell pellet (8 g) was resuspended in 40 ml of
native binding buffer (20 mM sodium phosphate, pH 7.8, 0.5 M NaCl). A protease inhibitor mixture for
polyhistidine-tagged proteins (0.4 ml; Sigma, Inc.) and lysozyme (100 µg/ml cell suspension) was added to the cell suspension followed by
incubation on ice for 15 min. The mixture was sonicated until it was no
longer viscous, and the cell debris was removed from the lysate by
centrifugation at 39,000 × g for 20 min at
4 °C.
The crude cell extract was applied to a 5-ml Ni2+-NTA
column (ProBond resin, Invitrogen Corp.) in native binding buffer. The column was then washed with 5 volumes of native wash buffer (20 mM sodium phosphate, pH 6.0, 0.5 M NaCl, 40 mM imidazole), and the HisRecE protein was eluted in a
gradient of 60 mM to 1 M imidazole in 20 mM sodium phosphate, pH 6.0, 0.5 M NaCl. The
fractions containing HisRecE, based on analysis by SDS-PAGE, were
collected and dialyzed against buffer A (20 mM Tris-HCl, pH
7.5, 1 mM DTT, 0.5 mM EDTA) containing 50 mM NaCl. The dialyzed pool was then applied to a 5-ml ssDNA
agarose column (Amersham Pharmacia Biotech) in buffer A containing 50 mM NaCl. The ssDNA-agarose column was washed with 1 volume
of buffer A containing 50 mM NaCl, and the HisRecE was eluted in a gradient of 50-400 mM NaCl in buffer A. The
fractions containing HisRecE were concentrated by ultrafiltration
(Amicon) and dialyzed against buffer A containing 50 mM
NaCl and 60% (v/v) glycerol. The resulting protein solution was stored
at 20 °C. The HisRecE protein concentration was determined from
the absorbance at 280 nm, using 280 = 102,840 M 1 cm 1 calculated for HisRecE
using the program ProtParam (ca.expasy.org/tools/protparam.html). The
typical yield was about 0.45 mg from a 2-liter culture. The mutant
HisRecE proteins and the C-terminal segment of RecE (see below) were
purified using these same procedures.
MALDI-TOF Mass Spectrometry--
The HisRecE protein was
prepared as described above, except that the purified protein was
dialyzed by ultrafiltration (Amicon) into 10 mM
NH4HCO3. A sample of HisRecE (18 mg/ml) was
diluted 10-fold by mixing with 0.1% trifluoroacetic acid. The diluted protein was mixed with an equal volume (0.3 µl) of sinapinic acid solution (50 mM in 70/30 v/v of acetonitrile, 0.1%
trifluoroacetic acid) and then characterized on a Kratos MALDI 4 TOF
mass spectrometer equipped with a 337 nm ultraviolet laser (Kratos
Analytical Instruments, UK). The mass spectrometer was externally
calibrated using bovine serum albumin. This test was kindly done by Dr.
Xudong Yao of Prof. Catherine Fenselau's research group at the
University of Maryland.
Exonuclease Assays--
The standard exonuclease reaction
conditions were 20 mM Tris-HCl, pH 8.0, 10 mM
MgCl2, 1 mM DTT, at 37 °C. The DNA substrate was 3H-labeled plasmid DNA
(pTZ19R-recEBHM or pPvSm19) linearized by
cleavage with HindIII. The RecE protein was diluted
10-50-fold when necessary in a buffer containing 10 mM
Tris-HCl, pH 7.5, 1 mM DTT, and 0.5 mg/ml bovine serum
albumin and was kept on ice. Nuclease activity was determined by
measuring the production of trichloroacetic acid-soluble mononucleotide products (22). The concentration of the RecE proteins is always given
as the monomer concentration, although the active form may be a larger
oligomer ((16) data not shown).
DNA Binding Assays--
DNA binding assays were done using the
two-filter method developed by Wong and Lohman (23) in which
DNA-protein complexes were trapped on a nitrocellulose filter (BA85,
Schleicher & Schuell), and the unbound DNA is trapped on a DEAE filter
(DE81, Whatman) put immediately beneath the nitrocellulose filter, as
described. The standard binding mixtures contained 20 mM
Tris-HCl, pH 8.0, 10 mM CaCl2, 1 mM
DTT, and [3H]pTZ19R-recEBHM DNA
(51.1 µM nt, equivalent to 12.7 nM ends). The
protein and DNA were mixed and incubated for 2 min at room temperature
before being applied to the nitrocellulose/DEAE filter sandwich.
The radioactivity bound to each dried filter was determined by liquid
scintillation counting. The fraction of DNA bound to the nitrocellulose
filter (f) was calculated as shown in Equation 1,
|
(Eq. 1)
|
where cpmNC and cpmDE are the counts
bound to the nitrocellulose and DEAE filters, respectively, for a given
binding mixture, and indicates cpmNC/cpmDE
for a mixture having no RecE enzyme. This corrects for the background
of DNA that binds nonspecifically to the nitrocellulose filter in the
absence of protein (23).
The filter binding data were then analyzed assuming that RecE molecules
can bind independently to each end of the DNA with identical
dissociation constant Kd. The binding data were fit
to Equation 2 (24) using the SigmaPlot program (SSPS, Inc.)
|
(Eq. 2)
|
where [RecE] is the free RecE concentration, and is the
probability that a DNA molecule with one RecE enzyme bound to one end
will not be retained on the filter (the fitted values of were very
small (~10 9) for most binding experiments).
Limited Proteolysis of the HisRecE Protein and N-terminal
Sequencing--
The purified HisRecE protein was treated with 6.25 µg of subtilisin Carlsberg per mg of HisRecE in buffer A (20 mM Tris-HCl, pH 7.5, 1 mM DTT, 0.5 mM EDTA) containing 50 mM NaCl and 60%
glycerol, at room temperature. Samples were removed at the indicated
times, quenched with 33 mM (final concentration)
phenylmethylsulfonyl fluoride (Sigma), and analyzed by SDS-PAGE.
HisRecE protein was also treated with trypsin (0.1 µg of trypsin per
mg of HisRecE) under the same conditions, at room temperature for 0-60
min. Samples were quenched and analyzed as above. To prepare the
samples for N-terminal sequencing, the digested protein bands in the
unstained SDS-polyacrylamide gel were transferred to a polyvinylidene
difluoride membrane (Millipore). The N-terminal sequencing was
performed by Dr. Brian Martin (National Institutes of Health).
Construction of a Plasmid to Express
HisRecE34kDa--
The 34-kDa C-terminal domain of RecE
protein (HisRecE34kDa) was also expressed using the vector
pET15b (Novagen, Inc.). The truncated recE gene was
transferred to the vector as follows. An 849-bp fragment from the
plasmid pET15b-recE was amplified by PCR. The downstream
primer annealed at the 3'-end of the gene (primer recE xho1,
see above), and the upstream primer annealed at nt 1692-1712 of
the gene (primer recE-34 nde1, 5'-CAG GAA CAT ATG
GAA CAT CCG CAC
AAT GAG AAT GC). Primer
recE-34 nde1 was partially complementary to the
recE gene (codons 564-571, underlined) and introduced an
NdeI site (bold) and an ATG start codon. The
truncated recE gene fragment was inserted into pET15b as
described above for the full-length recE gene. The plasmid containing
the truncated gene was identified by restriction digestion and DNA sequencing.
 |
RESULTS |
Purification and Monomer Molecular Weight of the HisRecE
Protein--
A protein of about 120-140 kDa was observed by SDS-PAGE
analysis of the lysate of cells transformed with
pET15b-recE, the RecE overexpression plasmid, after
induction with isopropyl- -D-thiogalactopyranoside (not
shown). This HisRecE protein can be purified in a single step by
chromatography on Ni2+-NTA resin, and further purification
can be achieved by chromatography on ssDNA-agarose. The apparent size
of this protein on SDS-PAGE is larger than the calculated molecular
weight of HisRecE (98 kDa; see Fig. 2).
Native RecE protein was found previously to migrate on SDS-PAGE with an
apparent molecular mass of 140 kDa (16), also greater than that
predicted from the recE DNA sequence (96 kDa; (25)). The
molecular mass of the purified HisRecE was determined by
MALDI-TOF mass spectrometry to be 99,274.2 Da (data not shown), in good
agreement for a protein of this size with the predicted molecular
mass (98,516 Da). This result shows that the HisRecE protein is
translated correctly and that the apparent molecular mass from
the SDS-PAGE is an overestimate.

View larger version (55K):
[in this window]
[in a new window]
|
Fig. 2.
Purified HisRecE and
HisRecE34-kDa proteins. HisRecE (10 µg) and
HisRecE34 kDa (10 µg) were analyzed on a 7.5%
polyacrylamide gel containing SDS and stained with Coomassie
Blue.
|
|
Nuclease Activity of HisRecE Protein--
The purified HisRecE
protein has ATP-independent nuclease activity on linear dsDNA (Fig.
3). The reaction time courses are linear
for the first ~10 min, but then the reactions slow down considerably
even though most of the substrate DNA has not been digested (Fig. 3).
The reaction resumed if more enzyme was added (data not shown),
indicating that the enzyme is unstable under the assay conditions, as
observed previously with the native RecE protein (16). The amount of
acid-soluble DNA product did not exceed about 50% of the total DNA
substrate present, even in reactions with high concentrations of active
HisRecE (not shown), consistent with degradation of only one strand of
the duplex by RecE (16). The specific activity of purified HisRecE,
determined from the linear part of the nuclease reaction time courses
(0-4 min), was as high as 200 mol of nucleotides produced per mol of
enzyme per min but varied somewhat among different enzyme preparations
(~50-200 min 1). The purified HisRecE protein retained
its activity for at least 3 months when stored at 20 °C in the
storage buffer, suggesting that there was variable loss of activity
during the purification procedure itself that accounted for the
irregularity among the different
preparations.2

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 3.
Exonuclease reactions with wild-type and
mutant HisRecE proteins. The reaction mixtures contained 20 mM Tris-HCl, pH 8.0, 1 mM DTT, 10 mM MgCl2, and 19.3 nM enzyme
(wild-type or mutant) and were incubated at 37 C. A, the
DNA substrate was [3H]pPvSm19 cleaved with
HindIII (121 µM nt; 19.3 nM dsDNA
ends) and wild-type HisRecE ( ), HisRecED748A
( ),HisRecED759A ( ), and HisRecEK761Q
( ). The reaction curves for the three mutants are superimposed along
the x axis in this plot. B, the DNA substrate was
[3H]pTZ19R-recEBHM cleaved with
HindIII (77.6 µM nt; 19 nM dsDNA
ends), and wild-type HisRecE ( ), HisRecEY785F ( ), and
HisRecEY785N ( ).
|
|
Mutagenesis of Residues in HisRecE That Are Conserved in the RecB
Nuclease Domain Family--
We made five mutations (D748A, D759A,
K761Q, Y785F, and Y785N) in the residues of the RecE protein that are
conserved among the RecB family members (Fig. 1). Asp-748, Asp-759, and
Lys-761 correspond to the residues that are important for the RecBCD
nuclease activities (4, 6). The mutant proteins
(HisRecED748A, HisRecED759A,
HisRecEK761Q, HisRecEY785F, and
HisRecEY785N) were expressed and purified by chromatography
on Ni2+-NTA and ssDNA-agarose exactly as for the wild-type
protein. All tests with the mutant HisRecE proteins (nuclease and DNA
binding) were done immediately after the proteins were purified (within 4 days or less), because at least one of the mutants
(HisRecEK761Q) gradually lost the ability to bind dsDNA
after about 1 month of storage at 20 °C.
Nuclease Activities of the Mutant Enzymes--
Nuclease assays
were done on the purified mutant enzymes with linear dsDNA under the
same reaction conditions used for the wild-type enzyme. The
HisRecED748A, HisRecED759A, and
HisRecEK761Q mutants had no detectable nuclease activity in
these reactions (Fig. 3A). The amount of acid-soluble DNA
produced by these mutant enzymes was indistinguishable from the
background of soluble radioactivity that was present initially in the
reaction mixture (0.5-1.5% of the total radioactivity present), in
reactions that were followed for 60 min. Wild-type HisRecE (19.3 nM) solubilized 10-20% of the linear DNA substrate in
~20 min under the same conditions (Fig. 3, A and
B).
The nuclease activity of the HisRecEY785F mutant was
similar to that of comparable amounts of the wild-type enzyme (Fig.
3B), and thus the mutation appeared to have essentially no
effect on the enzyme activity (the variability of the wild-type
specific activity does not allow a more rigorous comparison of their
activities). The removal of the hydroxyl group of Tyr-785 thus did not
have much effect on the exonuclease activity of HisRecE. The
HisRecEY785N mutant had very low but detectable activity
(~1% of the DNA was made acid-soluble in 60 min, after subtracting
out the background (Fig. 3B)). Thus the hydroxyl group of
Tyr-785 is not necessary for catalysis, but replacing the large
aromatic ring of Tyr or Phe with the smaller and more polar Asn side
chain may partially disrupt the structure of the enzyme leading to loss
of activity.3 Interestingly,
the conserved tyrosine in RecB (Tyr-1114; Fig. 1B) could be
changed to Phe or Ala with little if any effect on the nuclease
activity of RecBCD (6).
The Mutant Enzymes Bind to the Ends of Linear dsDNA with Similar
Affinity as the Wild-type Enzyme--
Protein-DNA binding assays were
done to test whether the mutant enzymes that were inactive as nucleases
had retained the ability to bind to the DNA substrate. Ca2+
was used in the binding buffer instead of Mg2+ because the
exonuclease activity of the RecE protein requires Mg2+ and
is inhibited by Ca2+ (16). Even though the
HisRecED748A, HisRecED759A, and
HisRecEK761Q mutant proteins have lost the ability to
hydrolyze DNA, they retain essentially the same DNA binding activity as
the wild-type protein (Fig. 4). The
equilibrium dissociation constants (Kd) were
obtained by fitting the binding data to Equation 2 (see "Experimental Procedures"). The Kd values for the wild-type,
HisRecED748A, HisRecED759A, and
HisRecEK761Q mutant proteins under these conditions are
182, 154, 85, and 77 nM, respectively, from duplicate
determinations.4 The
wild-type enzyme bound specifically to the DNA ends under these
conditions, because very little (~1%) of uncut circular plasmid DNA
was retained on the filter with 400 nM HisRecE (data not
shown).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 4.
HisRecE proteins binding to linear
double-stranded DNA. The binding mixtures contained 20 mM Tris-HCl, pH 8.0, 1 mM DTT, 10 mM CaCl2, linear
[3H]pTZ19R-recEBHM DNA (51.1 µM nt; 12.7 nM ends), and the indicated
concentrations of wild-type HisRecE ( ), HisRecED748A
( ), HisRecED759A ( ), and HisRecEK761Q
( ). The fraction of the DNA that was bound to the nitrocellulose
filter in the presence of HisRecE was measured as described under
"Experimental Procedures." The plotted data points are averages of
duplicate determinations, and the error bars show the
individual measured data points. The solid lines are the
nonlinear least squares fits of the data to Equation 2 (see
"Experimental Procedures").
|
|
The Nuclease Active Site of the RecE Protein Resides in a
C-terminal Domain of the RecE Protein--
Truncated RecE proteins, in
which as many as 587 residues are deleted from the N terminus and the
recE gene is fused to an upstream gene, retain high levels
of nuclease activity (18, 19) and recombination function in
vivo (20). We sought to test for the existence of separate
structural domains in RecE and further define their limits by
proteolysis experiments. HisRecE was treated with either trypsin or the
nonspecific protease subtilisin (26), and samples were taken at various
times and analyzed by SDS-PAGE. Several large fragments in the range
50-70 kDa were seen after short digestion times with subtilisin (Fig.
5 and data not shown), indicating that
there is no single site that is particularly prone to proteolysis.
These larger fragments were themselves cleaved by subtilisin, and they
disappeared at later times. Two small fragments of about 35 kDa
persisted and accumulated after lengthy digestion times (Fig. 5).
Trypsin also produced several large fragments (>50 kDa) at early times
that were degraded further, whereas a prominent band of ~28 kDa,
similar in size to the subtilisin fragments, accumulated (data not
shown).

View larger version (79K):
[in this window]
[in a new window]
|
Fig. 5.
Limited proteolysis of HisRecE protein with
subtilisin. The purified HisRecE protein (50 µg) was treated
with 0.32 µg of subtilisin Carlsberg in 20 mM Tris-HCl,
pH 7.5, 1 mM DTT, 0.5 mM EDTA, 50 mM NaCl, and 60% glycerol at room temperature. Samples
were quenched with phenylmethylsulfonyl fluoride (33 mM,
final concentration) at the indicated times and analyzed on a 15%
SDS-polyacrylamide gel. The 35- and 34-kDa fragments whose N-terminal
sequences were determined are indicated. The lane labeled
Subtilisin contained an amount of subtilisin equivalent to
that present in the samples taken from the digest mixture that were
loaded in the adjacent lanes.
|
|
The two polypeptide fragments of about 35 kDa that persisted after a
prolonged (2-h) incubation with subtilisin (Fig. 5) were transferred to
a polyvinylidene difluoride membrane and analyzed by automated Edman
degradation. The resulting N-terminal sequences (ENDPEEMEGAEH and
EHPHNENAG) correspond to residues 554-565 and 564-572 of RecE
protein, respectively. The calculated molecular masses of these two
polypeptide fragments were 35 and 34 kDa, assuming that they extend to
the C terminus of RecE.
The C-terminal 34-kDa Domain of RecE Is an Exonuclease--
The
34-kDa fragment beginning with residue 564 (HisRecE34kDa) was overexpressed and purified as for
the full-length enzyme. Unlike the full-length enzyme,
HisRecE34kDa migrates with the expected molecular weight on
the SDS gel (Fig. 2). Thus, the 60-kDa N-terminal segment of the RecE
protein contains sequences that cause the aberrant migration of RecE on
the SDS gel, as suggested previously (19, 25). The truncated
HisRecE34kDa has exonuclease activity with linear DNA (Fig.
6). The specific activity of
HisRecE34kDa was about the same as we observe for the
full-length protein (100-400 mol of nucleotides per mol enzyme per
min) and varied somewhat among different HisRecE34kDa
enzyme preparations, as described above for the full-length enzyme. The
amount of acid-soluble DNA produced by HisRecE34kDa did not
exceed more than about 50% of the total DNA substrate (Fig. 6),
consistent with degradation of only one strand by
HisRecE34kDa.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 6.
Nuclease assays with HisRecE34kDa
protein. The reaction mixtures were as in Fig. 3, with
[3H]pTZ19R-recEBHM cleaved with
HindIII (77.6 µM nt; 19.3 nM dsDNA
ends), and 3.89 nM HisRecE34kDa ( ), 7.7 nM HisRecE34kDa ( ), 19.5 nM
HisRecE34kDa ( ), 9.65 nM wild-type HisRecE
( ).
|
|
These results suggest that the RecE protein consists of a loosely
structured N-terminal region that is quite susceptible to proteolytic
degradation, and a more rigidly structured C-terminal domain of about
34 kDa that contains the exonuclease active site and is relatively
resistant to proteolysis. The results from deletion experiments (20)
suggest that smaller protein fragments can also be active, but the
proteolysis indicates that the ~34-kDa fragment may represent an
independently folded structural unit within the larger RecE protein.
 |
DISCUSSION |
Mutagenesis Experiments Support the Existence of the RecB Nuclease
Domain Family--
The results of the mutagenesis experiments in this
and previous reports (3, 4, 6) show that the E. coli RecE
and RecB proteins share an array of amino acid residues that are
critical for their nuclease activities in isolatable domains of about
the same size. Mutagenesis experiments were reported recently for a
third member of the RecB nuclease domain family, the Dna2 protein of
Saccharomyces cerevisiae (27, 28). The residues in Dna2 that
correspond to Asp-748, Asp-759, and Tyr-785 in RecE (see Fig.
1B) were found to be essential for the nuclease activity of
Dna2, supporting its inclusion in the RecB family. The domain structure
of Dna2 has not been investigated biochemically, and so it is not known
whether its nuclease activity can be localized to a smaller module of
this rather large protein (170 kDa in S. cerevisiae (28)).
Together these results support the hypothesis that the three proteins
are related to each other through common ancestry (8).
RecE and RecB Nucleases, Similar Catalytic Sites but Very Different
Enzymatic Activities--
Although RecE and RecB have the same
residues at their active sites, these two nucleases have very different
enzymatic properties. First, RecE has much higher specific activity
than RecB and especially than the RecB nuclease domain alone. The
isolated RecB domain has barely detectable nuclease activity (~0.002
phosphodiester bonds cleaved per h per protein molecule (5)), whereas
the full-length RecB protein cut about 0.5 bonds per h (4). Both are
strikingly less than RecE (~100-1000 cleavages per min). RecE and
RecB also have different substrate specificity and products. RecE is an
exonuclease that releases mononucleotides from the 5'-terminated strand
of a double-stranded substrate (17), whereas RecB cleaves
single-stranded DNA endonucleolytically (4). RecBCD has much greater
nuclease activity than RecB (4), but unlike RecE, it degrades dsDNA to
short single-stranded oligonucleotide fragments rather than to
mononucleotides (29), and it is able to cleave either strand of a dsDNA
molecule (30). Mutagenesis experiments indicate that RecB carries the
only nuclease active site in RecBCD (6), and so the activity and
specificity of the RecB nuclease domain must be altered quite
substantially once it has assembled with RecC and RecD to form RecBCD.
What Is the Relation of RecE to Other Bacteriophage
Proteins?--
We pointed out previously (6) that the residues shown
by mutagenesis to be essential for nuclease activity in RecE, RecB, and
Dna2 (the Asp ... Asp-Xaa-Lys sequence, Fig. 1B)
are similar to a motif found in a number of other nucleases including
several restriction endonucleases, the 5'-3'-exonuclease of
bacteriophage , and MutH: Pro-Asp ... (Asp/Glu)-Xaa-Lys
(31-33). These latter enzymes have little if any sequence similarity
with each other, but several have been found to have similar
three-dimensional structures, at least in their active site vicinity
(32-34).
A recent analysis by Koonin and colleagues (35) proposes a distant
relationship between the RecB family and these other nucleases that
have this active site motif, including the exonuclease, although
there is no readily detectable sequence similarity between the RecB
family and these other nucleases. This implies a distant connection
between the exonuclease and RecE. Indeed, the active site motif in
exonuclease, Pro-Asp ... Xaa9 ... Glu-Leu-Lys
(33), is very close to that of RecE (Pro-Asp ...
Xaa10 ... Asp-Val-Lys (Fig. 1B)). The RecE
nuclease domain (303 amino acid residues) is also roughly the same size
as exonuclease (226 residues). These observations thus are the
first biochemical evidence of any structural relationship between RecE
and the bacteriophage exonuclease. The affiliation of the two is
not unexpected because both enzymes are 5'-3'-specific exonucleases
that degrade one strand of a linear dsDNA substrate to mononucleotide
products (17). Moreover, the rac prophage that encodes RecE
is a lambdoid phage (14, 15), and the RecE protein most likely served
the same function for the progenitor of that phage as does the exonuclease (encoded by the red gene of bacteriophage
). On the other hand there was no previous hint of such a connection
from either sequence homology searches (8, 15, 19) or antibody
inhibition experiments (12).
The function, if any, of the large N-terminal extension of RecE is
unknown. There were no stable products from this region in the
proteolysis experiments, and it is not required for either the nuclease
or for the recombination activity of RecE (20). Perhaps the
recE gene once encoded a smaller nuclease corresponding to
the C-terminal domain of RecE (and about the same size as the RecB
nuclease domain and the exonuclease) that became fused to another
gene or to extraneous DNA as the rac prophage underwent genetic degradation after its irreversible entrapment in the
chromosome. The recE gene is not found in most bacteria, and
there are very few close homologues of E. coli RecE in the
sequence data bases. Thus the question of whether the N-terminal
extension is conserved cannot be addressed. However, an interesting
RecE homologue has been identified in a phage-like genetic element from
Legionella pneumophila (GenBankTM gene
identifier = 13,186,141 (36)). This 32-kDa (280 residues) protein
has 29% identity to residues 601-862 of the E. coli RecE protein (BLAST E value = 3 × 10 21),
including residues that align with the RecE/RecB nuclease active site
motif. The L. pneumophila protein may be a nuclease that is
a close relative of RecE but that includes only the nuclease domain and
lacks the N-terminal extension. The protein has not yet been purified
and tested for nuclease activity.
Evolutionary Implications--
The designation of a set of
proteins as a protein family based on detectable amino acid sequence
similarity among them implies their evolutionary descent from a common
ancestor (37, 38). On this basis, the RecB nuclease domain is an
evolutionarily mobile domain or protein "module" as defined in Ref.
39 that is found in proteins from Eubacteria, Archaea, bacteriophage,
and Eukaryota. The sequence analysis predicts that the nuclease module
has been joined to domains with other functions (helicase) in at least two family members (8), because Dna2 has a helicase domain like that in
RecB (Fig. 1A), and the isolated Dna2 protein has been
reported to unwind dsDNA (10). That the nuclease domain appears in both
a bacterial protein (RecB) and a phage protein (RecE) is presumably an
example of the frequent exchange of genetic information that occurs
between phages and their bacterial hosts (40, 41).
An alternative explanation for the similarity between RecE and RecB is
convergent evolution, whereby a small number of residues suitable for
catalyzing DNA cleavage (i.e. Asp-Asp-Lys) arose independently in two otherwise unrelated ancestral proteins. It has
been argued that convergent evolution to produce proteins with
significantly similar primary sequences (as opposed to similar three-dimensional structures without primary sequence similarity) is
very unlikely (42, 43). However, there is a "twilight zone" at low
percent sequence identity that is more difficult to judge, and the use
of sensitive sequence comparison programs that detect very subtle
sequence similarities might group some sequences together in a family
that are in fact examples of convergent evolution (42, 43). On the
other hand, it is clear that homologous proteins arising from divergent
evolution may have no detectable sequence similarity (39,
44, 45), and thus the low overall sequence similarity of RecE to RecB
cannot be taken to disprove the supposition that they have common
ancestry. High resolution structure information for RecE and RecB (and
other family members) could clinch the case for divergent evolution,
because true homologues should have similar folds with the active site
residues in comparable geometric arrangements on corresponding
secondary structural elements (46-49).
Conclusion--
Genome sequencing projects are adding tremendous
numbers of new open reading frame sequences to the data bases, many of
which encode proteins that appear to be unlike any that have been
studied before. Sequence comparison methods are critical for predicting possible functions for these hypothetical proteins. At the same time,
great effort is ongoing to refine the sequence analysis programs so
that they will detect ever more distantly related protein homologues
based on subtle sequence similarities (50, 51), such as those that
define the RecB nuclease domain family shown in Fig. 1B. The
results reported here on RecE and those with Dna2 cited above show that
these analysis methods have correctly identified critical residues in
these proteins despite their low sequence similarity. Most other
members of the RecB nuclease domain family are known so far only as
hypothetical open reading frames that have not been studied (8). Future
work may show whether these novel proteins are in fact nucleases and
what their biological functions are.
 |
ACKNOWLEDGEMENTS |
We are grateful to Prof. A. J. Clark,
University of California, Berkeley, for the gift of pRAC31, to Dr.
Brian Martin, National Institutes of Health, for N-terminal sequencing,
and to Dr. Xudong Yao and Prof. Catherine Fenselau of our department
for mass spectrometry.
 |
FOOTNOTES |
*
This work was supported by Grant GM39777 from the National
Institutes of Health.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 301-405-1821;
Fax: 301-314-9121; E-mail: dj13@umail.umd.edu.
Published, JBC Papers in Press, October 4, 2001, DOI 10.1074/jbc.M108627200
2
The specific activity of HisRecE was lower than
the values that can be estimated from the results for native RecE
obtained by Joseph and Kolodner (16) (~1000 min 1),
probably due to differences in the purification procedures used and in
the methods for protein concentration determination (Lowry method (16)
versus absorbance at 280 nm, using a calculated extinction
coefficient). Removing the 22-residue N-terminal His tag peptide by
treatment with thrombin (done with the purified His-tagged 34-kDa
nuclease domain protein) did not lead to any increase in the nuclease activity.
3
We also changed Tyr-785 to Ala in HisRecE
(HisRecEY785A mutant). A large fraction of the
overexpressed mutant enzyme was insoluble (much more so than for the
other mutants), and we were unable to purify HisRecEY785A
by the procedure that we used for the wild-type and the other mutants.
This suggests that the Tyr to Ala mutation affects the structure of
HisRecE.
4
Duplicate determinations agreed to within 20%.
The Kd value for HisRecEK761Q is from a
single determination.
 |
ABBREVIATIONS |
The abbreviations used are:
dsDNA, double-stranded DNA;
bp, base pair;
HisRecE, hexahistidine-tagged RecE
protein;
MALDI-TOF, matrix assisted laser desorption/ionization-time of
flight;
nt, nucleotide residue;
PCR, polymerase chain reaction;
NTA, nitrilotriacetic acid;
ssDNA, single-stranded DNA;
DTT, dithiothreitol.
 |
REFERENCES |
| 1.
|
Kowalczykowski, S. C.
(2000)
Trends Biochem. Sci.
25,
156-165[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Boehmer, P. E.,
and Emmerson, P. T.
(1992)
J. Biol. Chem.
267,
4981-4987[Abstract/Free Full Text]
|
| 3.
|
Yu, M.,
Souaya, J.,
and Julin, D. A.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
981-986[Abstract/Free Full Text]
|
| 4.
|
Yu, M.,
Souaya, J.,
and Julin, D. A.
(1998)
J. Mol. Biol.
283,
797-808[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Zhang, X. J.,
and Julin, D. A.
(1999)
Nucleic Acids Res.
27,
4200-4207[Abstract/Free Full Text]
|
| 6.
|
Wang, J.,
Chen, R.,
and Julin, D. A.
(2000)
J. Biol. Chem.
275,
507-513[Abstract/Free Full Text]
|
| 7.
|
Koonin, E. V.
(1992)
Trends Biochem. Sci.
17,
495-497[Medline]
[Order article via Infotrieve]
|
| 8.
|
Aravind, L.,
Walker, D. R.,
and Koonin, E. V.
(1999)
Nucleic Acids Res.
27,
1223-1242[Abstract/Free Full Text]
|
| 9.
|
Kooistra, J.,
Haijema, B. J.,
and Venema, G.
(1993)
Mol. Microbiol.
7,
915-923[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Budd, M. E.,
Choe, W. C.,
and Campbell, J. L.
(1995)
J. Biol. Chem.
270,
26766-26769[Abstract/Free Full Text]
|
| 11.
|
Bae, S. H.,
Choi, E.,
Lee, K. H.,
Park, J. S.,
Lee, S. H.,
and Seo, Y. S.
(1998)
J. Biol. Chem.
273,
26880-26890[Abstract/Free Full Text]
|
| 12.
|
Kushner, S. R.,
Nagaishi, H.,
and Clark, A. J.
(1974)
Proc. Natl. Acad. Sci. U. S. A.
71,
3593-3597[Abstract/Free Full Text]
|
| 13.
|
Willis, D. K.,
Satin, L. H.,
and Clark, A. J.
(1985)
J. Bacteriol.
162,
1166-1172[Abstract/Free Full Text]
|
| 14.
|
Campbell, A. M.
(1996)
in
Escherichia coli and Salmonella typhimurium
(Neidhardt, F. C., ed), Vol. 2
, pp. 2041-2046, American Society for Microbiology, Washington, D. C.
|
| 15.
|
Kolodner, R.,
Hall, S. D.,
and Luisi-DeLuca, C.
(1994)
Mol. Microbiol.
11,
23-30[Medline]
[Order article via Infotrieve]
|
| 16.
|
Joseph, J. W.,
and Kolodner, R.
(1983)
J. Biol. Chem.
258,
10411-10417[Abstract/Free Full Text]
|
| 17.
|
Joseph, J. W.,
and Kolodner, R.
(1983)
J. Biol. Chem.
258,
10418-10424[Abstract/Free Full Text]
|
| 18.
|
Luisi-DeLuca, C.,
Clark, A. J.,
and Kolodner, R. D.
(1988)
J. Bacteriol.
170,
5797-5805[Abstract/Free Full Text]
|
| 19.
|
Chu, C. C.,
Templin, A.,
and Clark, A. J.
(1989)
J. Bacteriol.
171,
2101-2109[Abstract/Free Full Text]
|
| 20.
|
Muyrers, J. P.,
Zhang, Y.,
Buchholz, F.,
and Stewart, A. F.
(2000)
Genes Dev.
14,
1971-1982[Abstract/Free Full Text]
|
| 21.
|
Korangy, F.,
and Julin, D. A.
(1992)
J. Biol. Chem.
267,
1727-1732[Abstract/Free Full Text]
|
| 22.
|
Korangy, F.,
and Julin, D. A.
(1992)
J. Biol. Chem.
267,
1733-1740[Abstract/Free Full Text]
|
| 23.
|
Wong, I.,
and Lohman, T. M.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
5428-5432[Abstract/Free Full Text]
|
| 24.
|
Woodbury, C. P.,
and von Hippel, P. H.
(1983)
Biochemistry
22,
4730-4737[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Clark, A. J.,
Sharma, V.,
Brenowitz, S.,
Chu, C. C.,
Sandler, S.,
Satin, L.,
Templin, A.,
Berger, I.,
and Cohen, A.
(1993)
J. Bacteriol.
175,
7673-7682[Abstract/Free Full Text]
|
| 26.
|
Hubbard, S. J.
(1998)
Biochim. Biophys. Acta
1382,
191-206[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Lee, K. H.,
Kim, D. W.,
Bae, S. H.,
Kim, J. A.,
Ryu, G. H.,
Kwon, Y. N.,
Kim, K. A.,
Koo, H. S.,
and Seo, Y. S.
(2000)
Nucleic Acids Res.
28,
2873-2881[Abstract/Free Full Text]
|
| 28.
|
Budd, M. E.,
Choe, W.,
and Campbell, J. L.
(2000)
J. Biol. Chem.
275,
16518-16529[Abstract/Free Full Text]
|
| 29.
|
Goldmark, P. J.,
and Linn, S.
(1972)
J. Biol. Chem.
247,
1849-1860[Abstract/Free Full Text]
|
| 30.
|
Anderson, D. G.,
Churchill, J. J.,
and Kowalczykowski, S. C.
(1997)
Genes Cells
2,
117-128[Abstract]
|
| 31.
|
Pingoud, A.,
and Jeltsch, A.
(1997)
Eur. J. Biochem.
246,
1-22[Medline]
[Order article via Infotrieve]
|
| 32.
|
Ban, C.,
and Yang, W.
(1998)
EMBO J.
17,
1526-1534[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Kovall, R. A.,
and Matthews, B. W.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
7893-7897[Abstract/Free Full Text]
|
| 34.
|
Aggarwal, A. K.
(1995)
Curr. Opin. Struct. Biol.
5,
11-19[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Aravind, L.,
Makarova, K. S.,
and Koonin, E. V.
(2000)
Nucleic Acids Res.
28,
3417-3432[Abstract/Free Full Text]
|
| 36.
|
Luneberg, E.,
Mayer, B.,
Daryab, N.,
Kooistra, O.,
Zahringer, U.,
Rohde, M.,
Swanson, J.,
and Frosch, M.
(2001)
Mol. Microbiol.
39,
1259-1271[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Murzin, A. G.
(1996)
Curr. Opin. Struct. Biol.
6,
386-394[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Henikoff, S.,
Greene, E. A.,
Pietrokovski, S.,
Bork, P.,
Attwood, T. K.,
and Hood, L.
(1997)
Science
278,
609-614[Abstract/Free Full Text]
|
| 39.
|
Doolittle, R. F.
(1995)
Annu. Rev. Biochem.
64,
287-314[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Hendrix, R. W.,
Smith, M. C.,
Burns, R. N.,
Ford, M. E.,
and Hatfull, G. F.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
2192-2197[Abstract/Free Full Text]
|
| 41.
|
Moreira, D.
(2000)
Mol. Microbiol.
35,
1-5[CrossRef][Medline]
[Order article via Infotrieve]
|
| 42.
|
Patterson, C.
(1988)
Mol. Biol. Evol.
5,
603-625[Abstract]
|
| 43.
|
Doolittle, R. F.
(1994)
Trends Biochem. Sci.
19,
15-18[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Rost, B.
(1997)
Fold. Des.
2,
S19-24[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Ponting, C. P.,
Schultz, J.,
Copley, R. R.,
Andrade, M. A.,
and Bork, P.
(2000)
Adv. Protein Chem.
54,
185-244[Medline]
[Order article via Infotrieve]
|
| 46.
|
Orengo, C. A.,
Jones, D. T.,
and Thornton, J. M.
(1994)
Nature
372,
631-634[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Murzin, A. G.
(1998)
Curr. Opin. Struct. Biol.
8,
380-387[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Matsuo, Y.,
and Bryant, S. H.
(1999)
Proteins
35,
70-79[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Wolf, Y. I.,
Grishin, N. V.,
and Koonin, E. V.
(2000)
J. Mol. Biol.
299,
897-905[CrossRef][Medline]
[Order article via Infotrieve]
|
| 50.
|
Park, J.,
Karplus, K.,
Barrett, C.,
Hughey, R.,
Haussler, D.,
Hubbard, T.,
and Chothia, C.
(1998)
J. Mol. Biol.
284,
1201-1210[CrossRef][Medline]
[Order article via Infotrieve]
|
| 51.
|
Schaffer, A. A.,
Aravind, L.,
Madden, T. L.,
Shavirin, S.,
Spouge, J. L.,
Wolf, Y. I.,
Koonin, E. V.,
and Altschul, S. F.
(2001)
Nucleic Acids Res.
29,
2994-3005[Abstract/Free Full Text]
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. Sisakova, L. K. Stanley, M. Weiserova, and M. D. Szczelkun
A RecB-family nuclease motif in the Type I restriction endonuclease EcoR124I
Nucleic Acids Res.,
July 1, 2008;
36(12):
3939 - 3949.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Davison, B. L. Trus, N. Cheng, A. C. Steven, M. S. Watson, C. Cunningham, R.-M. L. Deuff, and T. Renault
A novel class of herpesvirus with bivalve hosts
J. Gen. Virol.,
January 1, 2005;
86(1):
41 - 53.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. S. Vellani and R. S. Myers
Bacteriophage SPP1 Chu Is an Alkaline Exonuclease in the SynExo Family of Viral Two-Component Recombinases
J. Bacteriol.,
April 15, 2003;
185(8):
2465 - 2474.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|